DE69028710D1 - Arzneiabgabesystem, verfahren zu dessen herstellung sowie dessen verwendung - Google Patents
Arzneiabgabesystem, verfahren zu dessen herstellung sowie dessen verwendungInfo
- Publication number
- DE69028710D1 DE69028710D1 DE69028710T DE69028710T DE69028710D1 DE 69028710 D1 DE69028710 D1 DE 69028710D1 DE 69028710 T DE69028710 T DE 69028710T DE 69028710 T DE69028710 T DE 69028710T DE 69028710 D1 DE69028710 D1 DE 69028710D1
- Authority
- DE
- Germany
- Prior art keywords
- delivery system
- drug delivery
- active substances
- production
- dispensing system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8903503A SE465950B (sv) | 1989-10-23 | 1989-10-23 | Kombination av ett aggregat partikelformat, kristallint eller frystorkat laekemedel med en pseudoplastisk gel foer beredning av ett injicerbart preparat samt foerfarande foer dess framstaellning |
PCT/SE1990/000683 WO1991005544A1 (en) | 1989-10-23 | 1990-10-22 | Drug delivery system, method for preparing the same, and use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69028710D1 true DE69028710D1 (de) | 1996-10-31 |
DE69028710T2 DE69028710T2 (de) | 1997-04-17 |
Family
ID=20377242
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69028710T Expired - Lifetime DE69028710T2 (de) | 1989-10-23 | 1990-10-22 | Arzneiabgabesystem, verfahren zu dessen herstellung sowie dessen verwendung |
Country Status (9)
Country | Link |
---|---|
US (1) | US5614221A (de) |
EP (1) | EP0497846B1 (de) |
JP (1) | JP3017801B2 (de) |
AT (1) | ATE143257T1 (de) |
AU (1) | AU632634B2 (de) |
CA (1) | CA2067228C (de) |
DE (1) | DE69028710T2 (de) |
SE (1) | SE465950B (de) |
WO (1) | WO1991005544A1 (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE784487T1 (de) * | 1993-03-19 | 1999-11-04 | Q Med Ab Uppsala | Ein präparat und ein verfahren zur gewebevermehrung |
US5716631A (en) * | 1995-09-29 | 1998-02-10 | Rdn Therapeutics Inc. | Long acting narcotic analgesics and antagonists |
CN1126537C (zh) * | 1996-05-23 | 2003-11-05 | 株式会社三养社 | 可局部给药,可生物降解和持续释放的用于治疗牙周炎的药物组合物及其制备方法 |
DE69705746T2 (de) * | 1996-12-20 | 2001-10-31 | Alza Corp | Injizierbare depotgelzubereitung und herstellungsverfahren |
US7919109B2 (en) | 1999-02-08 | 2011-04-05 | Intarcia Therapeutics, Inc. | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles |
US7258869B1 (en) * | 1999-02-08 | 2007-08-21 | Alza Corporation | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle |
US7582311B1 (en) | 1999-10-15 | 2009-09-01 | Genentech, Inc. | Injection vehicle for polymer-based formulations |
US7651703B2 (en) | 1999-10-15 | 2010-01-26 | Genentech, Inc. | Injection vehicle for polymer-based formulations |
AU2002320122B2 (en) | 2001-06-21 | 2007-07-26 | Genentech, Inc. | Sustained release formulation |
US20060094643A1 (en) * | 2002-07-03 | 2006-05-04 | Yuri Svirkin | Compositions of hyaluronic acid and methods of use |
US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
FR2850282B1 (fr) | 2003-01-27 | 2007-04-06 | Jerome Asius | Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
DE602007009377D1 (de) | 2006-05-30 | 2010-11-04 | Intarcia Therapeutics Inc | Zweiteiliger flussmodulator mit einem internen kanal für ein osmotisches ausgabesystem |
KR101200728B1 (ko) | 2006-08-09 | 2012-11-13 | 인타르시아 세라퓨틱스 인코포레이티드 | 삼투성 전달 시스템 및 피스톤 조립체 |
AU2008244523B2 (en) | 2007-04-23 | 2012-02-16 | Intarcia Therapeutics, Inc. | Suspension formulations of insulinotropic peptides and uses thereof |
US8968786B2 (en) | 2007-06-22 | 2015-03-03 | Board Of Regents, The University Of Texas System | Formation of stable submicron peptide or protein particles by thin film freezing |
EP2240155B1 (de) | 2008-02-13 | 2012-06-06 | Intarcia Therapeutics, Inc | Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe |
JP5711138B2 (ja) | 2008-11-16 | 2015-04-30 | ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム | 高濃度の低粘度懸濁液 |
SI2462246T1 (en) | 2009-09-28 | 2018-01-31 | Intarcia Therapeutics, Inc. | Fast-setting and / or cessation of substantially unchanged delivery of the product |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
KR20240042548A (ko) | 2015-06-03 | 2024-04-02 | 인타르시아 세라퓨틱스 인코포레이티드 | 임플란트 배치 및 제거 시스템들 |
MA53353A (fr) | 2016-05-16 | 2021-06-09 | Intarcia Therapeutics Inc | Polypeptides sélectifs pour le récepteur du glucagon et méthodes pour leur utilisation |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
EP3565580B1 (de) | 2017-01-03 | 2024-03-06 | i2o Therapeutics, Inc. | Kontinuierlicher verabreichung von exenatid und co-verabreichung von acetaminophen, ethinylestradiol oder levonorgestrel |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3663685A (en) * | 1968-04-01 | 1972-05-16 | Minnesota Mining & Mfg | Biodegradable radioactive particles |
US4169804A (en) * | 1976-08-19 | 1979-10-02 | Minnesota Mining And Manufacturing Company | Magnetically responsive composite microparticle |
US4474752A (en) * | 1983-05-16 | 1984-10-02 | Merck & Co., Inc. | Drug delivery system utilizing thermosetting gels |
DE3484584D1 (de) * | 1983-10-14 | 1991-06-20 | Sumitomo Pharma | Injektionen mit verzoegerter abgabe. |
US4624665A (en) * | 1984-10-01 | 1986-11-25 | Biotek, Inc. | Method of transdermal drug delivery |
IT1186766B (it) * | 1985-11-08 | 1987-12-16 | Sclavo Spa | Metodo per la preparazione di immunoglobuline per uso endovenoso |
DE3684887D1 (de) * | 1985-11-29 | 1992-05-21 | Biomatrix Inc | Arzneistoffabgabesysteme auf basis von hyaluronan, dessen derivaten und salzen sowie verfahren zu deren herstellung. |
JPS63624A (ja) * | 1986-06-19 | 1988-01-05 | Nec Corp | 正規乱数発生方法 |
DE3626868A1 (de) * | 1986-08-08 | 1988-02-11 | Bayer Ag | Parenterale loesung |
-
1989
- 1989-10-23 SE SE8903503A patent/SE465950B/sv not_active IP Right Cessation
-
1990
- 1990-10-22 CA CA002067228A patent/CA2067228C/en not_active Expired - Lifetime
- 1990-10-22 EP EP90916175A patent/EP0497846B1/de not_active Expired - Lifetime
- 1990-10-22 DE DE69028710T patent/DE69028710T2/de not_active Expired - Lifetime
- 1990-10-22 WO PCT/SE1990/000683 patent/WO1991005544A1/en active IP Right Grant
- 1990-10-22 AU AU66237/90A patent/AU632634B2/en not_active Expired
- 1990-10-22 AT AT90916175T patent/ATE143257T1/de not_active IP Right Cessation
- 1990-10-22 JP JP2514918A patent/JP3017801B2/ja not_active Expired - Lifetime
-
1994
- 1994-11-21 US US08/344,707 patent/US5614221A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2067228C (en) | 2002-01-08 |
SE8903503L (sv) | 1991-04-24 |
JP3017801B2 (ja) | 2000-03-13 |
SE8903503D0 (sv) | 1989-10-23 |
AU632634B2 (en) | 1993-01-07 |
WO1991005544A1 (en) | 1991-05-02 |
US5614221A (en) | 1997-03-25 |
AU6623790A (en) | 1991-05-16 |
CA2067228A1 (en) | 1991-04-24 |
JPH05503921A (ja) | 1993-06-24 |
EP0497846B1 (de) | 1996-09-25 |
DE69028710T2 (de) | 1997-04-17 |
EP0497846A1 (de) | 1992-08-12 |
ATE143257T1 (de) | 1996-10-15 |
SE465950B (sv) | 1991-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69028710D1 (de) | Arzneiabgabesystem, verfahren zu dessen herstellung sowie dessen verwendung | |
GB2335357B (en) | Chitosan-gelatin a microparticles | |
PT97369A (pt) | Processo para a preparacao de formulacoes farmaceutica na qual o sabor do medicamento e disfarcado por meio de revestimento do medicamento com uma membrana polimerica | |
DE69433723D1 (de) | Verfahren für die in-vivo-verabreichung von biologischen substanzen und hierfür verwendbare zusammensetzungen | |
ATE122879T1 (de) | Verabreichungsformen für pharmaka. | |
DE68920578T2 (de) | Verschiedenartige Zelluloseether enthaltende, oral verabreichbare Arzneimittelformen mit gesteuerter Wirkstofffreigabe. | |
DE69519685D1 (de) | Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe | |
KR950702409A (ko) | 방출 조절 모르핀 제제(controlled release morphine preparation) | |
ES2184895T3 (es) | Sistema no polimerico de administracion con liberacion retardada. | |
HU76547A2 (en) | Process for producing pharmaceutical compositions containing agent in polymer-matrix and in solid solution form and these medicaments | |
EP1126881B1 (de) | Mucoadhäsive polymere, deren verwendung sowie deren herstellungsverfahren | |
NZ501950A (en) | Medicinal compositions for application to mucosa | |
AR034640A1 (es) | Composicion de liberacion sostenida y proceso para producirla | |
DE69431800D1 (de) | Arzneiverabreichungssystem | |
EP4103769A1 (de) | Natürliche zusammensetzung auf der basis von polymeren zum elektrospinnen und verfahren zu deren herstellung | |
ATE282406T1 (de) | Arzneimittel und verfahren zur behandlung von intrazellulären infektionen | |
HUP0203908A2 (hu) | Ozmotikus adagolórendszer és eljárás elsősorban gyógyszer adagolására | |
DE60007074D1 (de) | Sulfatierte phosphatidylinositole, ihre herstellung und verwendung | |
PL317996A1 (en) | Carbamazepinic form of a drug with retarded release of biologically active substance | |
SE9503620L (sv) | Användning av proteinet S-100b för framställning av läkemedel för nervceller | |
WO2023170718A1 (en) | Composition to be electrospun | |
EP1288311A3 (de) | Methode zum testen von wirkstoffen hinsichtlich der aktivierung von pax4 und der produktion von insulin produzierenden beta-zellen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |